Amarin Corp Plc (AMRN)

[rosemountbomber]

But I think that is inherent in all clinical trials (depending on the phase obviously). Late stage trials will measure efficacy at interim so Reduce it is no different. The monitoring committee can stop the trial for safety reasons and also in conference with FDA and company the trial can be stopped because of either futility or tremendous success where it would be deemed ruthless not to put everyone on a beneficial treatment.